NDC 63629-3253-01 - DAPAGLIFLOZIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-3253
- Requested NDC
- 63629-3253-01
- Package NDCs from labels
- 63629-3253-1, 63629-3253-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-08-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DAPAGLIFLOZIN - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-08-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-3253-1 | DAPAGLIFLOZIN | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 101 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-3253 | DAPAGLIFLOZIN TABLET, FILM COATED [BRYANT RANCH PREPACK] | 101 | Current NDC, 1 package rows | 20240820_979205ee-b0b8-4483-ae61-f283f750bb7f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-3253-1 | EA - Each | 63629-3253 | 5c0402f4-8915-4804-9c4b-c44510c4c3a5 | 1 | 2025-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bioplasma | SILICON DIOXIDE,POTASSIUM CHLORIDE,SODIUM SULFATE,FERROSOFERRIC PHOSPHATE,MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE,SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE,TRIBASIC CALCIUM PHOSPHATE,POTASSIUM PHOSPHATE, DIBASIC,POTASSIUM SULFATE,SODIUM CHLORIDE,CALCIUM SULFATE ANHYDROUS,CALCIUM FLUORIDE | Hyland's Inc. | dd0a7ed2-d112-4b96-e053-2995a90ac6b6 | 2026-07-30 | Warnings | ETJ7Z6XBU4 |
| Dapagliflozin | DAPAGLIFLOZIN | Sandoz Inc | 8296f538-4c23-4d6c-be53-8005b83c24b7 | 2026-07-30 | Warnings, Adverse reactions | 1488574 1488569 |
| Dapagliflozin | DAPAGLIFLOZIN | Aurobindo Pharma Limited | f56593f7-588e-489d-9fad-b459e90dab18 | 2026-07-17 | Warnings, Adverse reactions | 1488574 1488569 |
| Prid | ICHTHAMMOL, CALCIUM SULFIDE, CALENDULA OFFICINALIS FLOWERING TOP, ARNICA MONTANA, ECHINACEA ANGUSTIFOLIA, SILICON DIOXIDE, SULFUR | Hyland's Inc. | 49689eeb-7790-07f1-e063-6294a90a2df2 | 2026-07-16 | Warnings | ETJ7Z6XBU4 |
| FARXIGA | DAPAGLIFLOZIN | A-S Medication Solutions | 01f90c94-71cb-4a1f-81ff-8004b850529b | 2026-07-10 | Warnings, Adverse reactions | NDA202293 1488574 1488569 887K2391VH |
| Jacksons Cell Salts SILICA 12X 12 | SILICEA | Zettl Health Inc. | 5647dafc-1fff-6a25-e063-6294a90a8b4f | 2026-07-10 | ETJ7Z6XBU4 | |
| dapagliflozin | DAPAGLIFLOZIN | Macleods Pharmaceuticals Limited | 91373924-66dc-4277-aaf2-8536e81a0e4d | 2026-07-09 | Warnings, Adverse reactions | 1488574 1488569 |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Florida Pharmaceutical Products, LLC | 20a83ea2-6ad8-4bbb-b516-73c0a9e37399 | 2026-07-02 | Warnings, Adverse reactions | 1488574 1488569 |
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | ETJ7Z6XBU4 |
| Bambusa Stannum | BAMBUSA STANNUM | Uriel Pharmacy Inc. | a0d4d0ac-e2d2-4381-8f93-e41719521859 | 2026-06-30 | Warnings | ETJ7Z6XBU4 |
| Dapagliflozin | DAPAGLIFLOZIN | ANI Pharmaceuticals, Inc. | 6425d240-5dd9-4a2c-9348-f8a859702850 | 2026-06-29 | Warnings, Adverse reactions | 1488574 1488569 |
| Dapagliflozin | DAPAGLIFLOZIN | Lupin Pharmaceuticals, Inc. | 08baca21-e39e-4e61-961f-d89432fe8007 | 2026-06-26 | Warnings, Adverse reactions | 1488574 1488569 |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Alembic Pharmaceuticals Inc. | 840e2146-2383-489b-bcc4-fecfe986685a | 2026-06-23 | Warnings, Adverse reactions | 1488574 1488569 |
| Dapagliflozin | DAPAGLIFLOZIN | Zydus Pharmaceuticals USA Inc. | 17586ec6-0104-4b08-ad87-12a837568d6c | 2026-06-22 | Warnings, Adverse reactions | 1488574 1488569 |
| DAPAGLIFLOZIN | DAPAGLIFLOZIN | Cipla USA Inc. | a2f86c0a-ce78-4d06-b5d8-ed457c8e3614 | 2026-06-22 | Warnings, Adverse reactions | 1488574 1488569 887K2391VH |
| Dapagliflozin | DAPAGLIFLOZIN | Novadoz Pharmaceuticals LLC | 107b4d25-4764-42b7-80e3-9aaff20865ed | 2026-06-17 | Warnings, Adverse reactions | 1488574 1488569 |
| H-Scars Formula | CALENDULA OFFICINALLIS, SILICEA | Healing Natural Oils LLC | 8433ff00-d815-45e0-b0ec-1448668dd8f8 | 2026-06-16 | Warnings | ETJ7Z6XBU4 |
| E-Z-GAS II | ANTACID/ANTIFLATULENT | E-Z-EM, INC. | 4e12e1cb-b033-076d-e054-00144ff8d46c | 2026-06-15 | Warnings | ETJ7Z6XBU4 |
| BM BIO28 ALCOHOL | CALC SULPH, CALC FLUOR, CALC PHOS, FERR PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT PHOS, NAT SULPH, NAT MUR, SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 544b66c4-49df-556f-e063-6394a90af3ed | 2026-06-15 | Warnings | ETJ7Z6XBU4 |
| BM Tooth Remineralization | CALC PHOS, CALC FLUOR, SILICEA | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 543bc298-ec32-38e9-e063-6394a90aac15 | 2026-06-14 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.